✦ LIBER ✦

Lipid-lowering agents in chronic kidney disease: do fibrates have a role?

✍ Scribed by Huang, Yuli; Hu, Yunzhao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LIPID-LOWERING THERAPY IN CHRONIC KIDNEY

✍ Darren Green; Rosica Panayotova; James P. Ritchie; Edmond O’Riordan; John McDona 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 487 KB

Current developments in lipid-lowering t

✍ Burnhope, Emma; Green, Darren; Kalra, Philip A; Kalra, Paul R 📂 Article 📅 2011 🏛 Future Medicine 🌐 English ⚖ 641 KB

Lipid lowering in patients with chronic

✍ Berthold, Heiner K ;Krone, Wilhelm ;Erdmann, Erland ;Gouni-Berthold, Ioanna 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 139 KB

Intensive Lipid Lowering With Atorvastat

✍ Shepherd, James; Kastelein, John J.P.; Bittner, Vera A.; Carmena, Rafael; Deedwa 📂 Article 📅 2008 🏛 Mayo Clinic 🌐 English ⚖ 219 KB

Prevention of Sudden Death in Patients W

✍ Johan De Sutter; Vida Firsovaite; Rene Tavernier 📂 Article 📅 2002 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 910 KB

PUK5 DOES RACIAL VARIATION IN RISK FACTO

✍ J Shah; R Nair 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB